网站主页>>>数据中心>>>工艺路线数据>>>Selpercatinib CAS# 2152628-33-4 塞卡替尼

Selpercatinib CAS# 2152628-33-4 塞卡替尼

Selpercatinib, also known as LOXO-292, is a potent and selective RET inhibitor with antineoplastic properties. LOXO-292 selectively binds to and targets various RET mutants and RET-containing fusion products. This results in an inhibition of cell growth of tumors cells that exhibit increased RET activity. Selpercatinib was approved in May 2020.
📌 参考资料/链接:
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile and intermediates thereofBy: AnonymousIP.com Journal (2021), 21(2B), 1-10

📄 详细内容

CAS No. 2152628-33-4 塞卡替尼Selpercatinib synthetic routes


Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile and intermediates thereofBy: AnonymousIP.com Journal (2021), 21(2B), 1-10
产品链接: CAS No. 2152628-33-4 ››